Cargando…
Molecular and Immunological Characterization of Biliary Tract Cancers: A Paradigm Shift Towards a Personalized Medicine
Biliary tract cancers (BTCs) are a group of rare cancers that account for up to 3–5% of cancer patients worldwide. BTCs include cholangiocarcinoma (CCA), gallbladder cancer (GBC), and ampulla of Vater cancer (AVC). They are frequently diagnosed at an advanced stage when the disease is often found di...
Autores principales: | Malenica, Ines, Donadon, Matteo, Lleo, Ana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7464597/ https://www.ncbi.nlm.nih.gov/pubmed/32781527 http://dx.doi.org/10.3390/cancers12082190 |
Ejemplares similares
-
Paradigm shift of chemotherapy and systemic treatment for biliary tract cancer
por: Leowattana, Wattana, et al.
Publicado: (2023) -
The Shifting Paradigm of Prognostic Factors of Colorectal Liver Metastases: From Tumor-Centered to Host Immune-Centered Factors
por: Donadon, Matteo, et al.
Publicado: (2018) -
Personalized medicine: A paradigm shift towards promising health care
por: Annadurai, Kalaivani, et al.
Publicado: (2016) -
Pharmacogenetics, Pharmacogenomics and Ayurgenomics for Personalized Medicine: A Paradigm Shift
por: Gupta, Pooja D.
Publicado: (2015) -
Biliary Tract Cancers: Molecular Heterogeneity and New Treatment Options
por: Personeni, Nicola, et al.
Publicado: (2020)